Jim Simons’s Biomerica BMRA Stock Holding History

Jim Simons’s Portfolio BMRA Stock Details BMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,500	Closed	-$153K	–	3465
2021 Q1	$153K	Sell	3,500 -1,735	-33%	-$88.9K	﹤0.01%	3183
2020 Q4	$209K	Buy	+5,235	New	+$262K	﹤0.01%	3120

Other funds holding BMRA

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fore Capital New York $338M AUM 10.07% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HIMC

Heritage Investors Management Corp Bethesda, Maryland $3.61B AUM 35.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Jim Simons's BMRA Position: Q2 2021 in Review

Jim Simons sold out of Biomerica (BMRA) in Q2 2021, closing a stake of 3,500 shares — an estimated $153K sold.

Jim Simons first reported a position in BMRA in Q4 2020 and held it in 2 quarters. The position peaked at $209K in Q4 2020. 26 funds tracked by Wall St. Rank hold BMRA as of Q2 2021.

Jim Simons reported no remaining Biomerica position as of Q2 2021 after selling out during the quarter.
Jim Simons sold 3,500 Biomerica shares in Q2 2021, an estimated $153K.
Jim Simons first reported a position in Biomerica in Q4 2020 and held it in 2 quarters.
Jim Simons's Biomerica position peaked at $209K in Q4 2020.
26 funds tracked by Wall St. Rank held Biomerica as of Q2 2021.

Based on Renaissance Technologies's 13F filing for Q2 2021, filed 13 Aug 2021.